
According to data from Benzinga Pro, during Q1, Evolus's (NASDAQ:EOLS) reported sales totaled $33.91 million. Despite a 3.72% increase in earnings, the company posted a loss of $17.50 million. In Q4, Evolus brought in $34.66 million in sales but lost $18.18 million in earnings.